Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Function Impairment in Healthy Volunteers”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05611957
What this trial is testing

LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Who this might be right for
HealthyRenal Insufficiency
Eli Lilly and Company 29
Early research (Phase 1)Study completedNCT06246175
What this trial is testing

HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Early research (Phase 1)Study completedNCT03657784
What this trial is testing

Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Renal InsufficiencyHealthy Volunteers
Guerbet 40
Early research (Phase 1)UnknownNCT06039254
What this trial is testing

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

Who this might be right for
Chronic Kidney Disease
Shandong Suncadia Medicine Co., Ltd. 27
Early research (Phase 1)Looking for participantsNCT07322016
What this trial is testing

HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hyperlipidemias
Shandong Suncadia Medicine Co., Ltd. 36
Early research (Phase 1)Study completedNCT01245790
What this trial is testing

Fostamatinib in Subjects With Impaired Kidney Function

Who this might be right for
Rheumatoid ArthritisRenal Impairment
AstraZeneca 24
Early research (Phase 1)Study completedNCT02992236
What this trial is testing

Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

Who this might be right for
Renal Function Impairment in Healthy Volunteers
veriNOS operations GmbH 16
Early research (Phase 1)Study completedNCT03687554
What this trial is testing

Effect of Venglustat in Patients With Renal Impairment

Who this might be right for
Healthy VolunteersPolycystic Kidney, Autosomal Dominant
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT04881994
What this trial is testing

Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureDiabetic Nephropathy
Bayer 27
Early research (Phase 1)Ended earlyNCT04252430
What this trial is testing

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Who this might be right for
Healthy VolunteersImpaired Renal Function
MedDay Pharmaceuticals SA 24
Post-approval studies (Phase 4)Study completedNCT01770652
What this trial is testing

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment

Who this might be right for
Renal Impairment
ApoPharma 32
Early research (Phase 1)Ended earlyNCT01359579
What this trial is testing

The Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Who this might be right for
Renal Impairment
Anthera Pharmaceuticals 28
Early research (Phase 1)Study completedNCT02646358
What this trial is testing

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Who this might be right for
Pharmacokinetics of VepoloxamerHealthy VolunteersRenal Impaired
Mast Therapeutics, Inc. 27
Early research (Phase 1)Study completedNCT03680352
What this trial is testing

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
PK in Patients With Various Degrees of Renal Impairment
Allecra 30
Early research (Phase 1)Study completedNCT05505955
What this trial is testing

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Who this might be right for
Glomerulonephritis
Chengdu Suncadia Medicine Co., Ltd. 83
Early research (Phase 1)Study completedNCT02634437
What this trial is testing

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

Who this might be right for
Renal Function
Allergan 19
Early research (Phase 1)Study completedNCT00426036
What this trial is testing

Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine

Who this might be right for
Healthy
Novartis 12
Early research (Phase 1)Study completedNCT03605277
What this trial is testing

Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT05282030
What this trial is testing

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.

Who this might be right for
Renal Impairment
Sanofi 22
Early research (Phase 1)Study completedNCT04024332
What this trial is testing

Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects

Who this might be right for
Renal InsufficiencyHealthy
Idorsia Pharmaceuticals Ltd. 16
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation